Moderna taps former Millennium CSO Joseph Bolen as its new R&D president

Another Millennium executive has left the pharmaceuticals giant to pursue other opportunities. Dr. Joseph Bolen, has left his role of chief scientific office and global head of research at Millennium to lead the research and development charge at Moderna Therapeutics, a biotech that is focused on RNA therapeutics...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.